Exchange Traded Concepts’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Sell |
2,586
-37
| -1% | -$16.5K | 0.01% | 621 |
|
|
2025
Q1 | $1.27M | Sell |
2,623
-322
| -11% | -$156K | 0.02% | 480 |
|
|
2024
Q4 | $1.19M | Sell |
2,945
-13
| -0.4% | -$5.24K | 0.02% | 505 |
|
|
2024
Q3 | $1.38M | Sell |
2,958
-2,355
| -44% | -$1.1M | 0.03% | 421 |
|
|
2024
Q2 | $2.49M | Sell |
5,313
-128
| -2% | -$60K | 0.06% | 254 |
|
|
2024
Q1 | $2.27M | Sell |
5,441
-2,318
| -30% | -$969K | 0.06% | 277 |
|
|
2023
Q4 | $3.16M | Sell |
7,759
-1,371
| -15% | -$558K | 0.08% | 191 |
|
|
2023
Q3 | $3.17M | Buy |
9,130
+799
| +10% | +$278K | 0.09% | 177 |
|
|
2023
Q2 | $2.93M | Sell |
8,331
-1,926
| -19% | -$678K | 0.07% | 217 |
|
|
2023
Q1 | $3.23M | Buy |
10,257
+1,761
| +21% | +$555K | 0.09% | 159 |
|
|
2022
Q4 | $2.45M | Sell |
8,496
-2,390
| -22% | -$690K | 0.07% | 170 |
|
|
2022
Q3 | $3.15M | Sell |
10,886
-867
| -7% | -$251K | 0.1% | 112 |
|
|
2022
Q2 | $3.31M | Sell |
11,753
-2,299
| -16% | -$648K | 0.1% | 117 |
|
|
2022
Q1 | $3.67M | Buy |
14,052
+1,942
| +16% | +$507K | 0.07% | 147 |
|
|
2021
Q4 | $2.66M | Sell |
12,110
-3,346
| -22% | -$735K | 0.05% | 215 |
|
|
2021
Q3 | $2.8M | Sell |
15,456
-11,217
| -42% | -$2.03M | 0.07% | 198 |
|
|
2021
Q2 | $5.38M | Buy |
26,673
+15,666
| +142% | +$3.16M | 0.17% | 88 |
|
|
2021
Q1 | $2.37M | Buy |
11,007
+4,132
| +60% | +$888K | 0.09% | 183 |
|
|
2020
Q4 | $1.63M | Buy |
6,875
+4,468
| +186% | +$1.06M | 0.08% | 179 |
|
|
2020
Q3 | $655K | Buy |
2,407
+1,059
| +79% | +$288K | 0.04% | 239 |
|
|
2020
Q2 | $391K | Buy |
1,348
+819
| +155% | +$238K | 0.06% | 245 |
|
|
2020
Q1 | $126K | Buy |
529
+101
| +24% | +$24.1K | 0.07% | 240 |
|
|
2019
Q4 | $94K | Buy |
+428
| New | +$94K | 0.02% | 205 |
|